910 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
Rank Status Study
1 Recruiting SAS in Patients With Bronchial Carcinoma
Conditions: Sleep Apnea Syndrome;   Bronchial Carcinoma
Intervention: Device: sleep apnea screening with ApneaLinkTM
2 Recruiting Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics
Conditions: Tumors;   Carcinoma, Bronchogenic;   Breast Carcinoma;   Cancer of Head and Neck;   Lymphoma, Malignant;   Soft Tissue Neoplasms
Intervention: Drug: 18F-Al-NOTA-PRGD2 PET/CT
3 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
4 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
5 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
6 Recruiting Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
Conditions: Stage IA Non-small Cell Lung Cancer;   Adenocarcinoma of the Lung;   Squamous Cell Lung Cancer
Intervention:
7 Recruiting Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors
Conditions: Breast Cancer;   Ovarian Epithelial Cancer Recurrent;   Sarcoma;   Non-small Cell Lung Cancer;   Carcinoma, Transitional Cell;   Prostate Cancer;   Prostatic Neoplasms
Intervention: Drug: Mifepristone and Eribulin in combination
8 Recruiting Comparison of Two Therapeutic Strategies in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) With Asymptomatic Brain Metastases
Conditions: Non-small Cell Lung Cancer Metastatic;   Non Epidermoid;   Non-small Cell Lung Cancer;   Adenocarcinoma of Lung Metastatic to Brain;   Cerebral Metastases;   Cerebral Radiotherapy;   Brain Radiotherapy;   Bevacizumab
Interventions: Drug: Cisplatin;   Drug: Pemetrexed;   Drug: Bevacizumab;   Radiation: Cerebral Radiotherapy
9 Recruiting Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of Avitinib in Advanced Non Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Avitinib
10 Not yet recruiting A Study of LY3023414 and Necitumumab in Squamous Lung Cancer
Condition: Non-small Cell Lung Cancer Metastatic
Interventions: Drug: LY3023414;   Drug: Necitumumab
11 Recruiting Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer
Conditions: Non-Small Cell Lung Cancer;   Positive EGFR Mutation
Intervention: Drug: BIBW 2992
12 Unknown  Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)
Condition: Nonsmall Cell Lung Cancer
Intervention: Drug: salvage iressa
13 Recruiting Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Patients With Small Cell Lung Cancer That Has Relapsed or Not Responded to Treatment
Condition: Recurrent Small Cell Lung Cancer
Interventions: Drug: doxorubicin hydrochloride;   Drug: topotecan hydrochloride;   Other: quality-of-life assessment;   Other: laboratory biomarker analysis
14 Recruiting Neuropharmacokinetics of Eribulin Mesylate in Patients With Brain Metastases From Breast, Bladder, or Non-small Cell Lung Cancer
Conditions: Breast Carcinoma Metastatic to the Brain;   Lung Carcinoma Metastatic to the Brain;   Metastatic Malignant Neoplasm to the Adult Brain;   Stage IV Bladder Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Procedure: Therapeutic Conventional Surgery;   Procedure: Biopsy;   Drug: Eribulin Mesylate;   Procedure: Microdialysis;   Other: Pharmacological Study
15 Recruiting Hydroxychloroquine and Gefitinib to Treat Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Gefitinib, Hydroxychloroquine
16 Recruiting Pemetrexed Plus Oxaliplatin as Adjuvant Chemotherapy for Radically Resected Non-Small Cell Lung Cancer
Condition: Non Small Cell Lung Cancer
Intervention: Drug: Pemetrexed/Oxaliplatin
17 Not yet recruiting Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer
Interventions: Drug: pemetrexed disodium;   Drug: carboplatin;   Drug: cisplatin;   Drug: erlotinib hydrochloride;   Other: laboratory biomarker analysis
18 Recruiting Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC
Condition: Stage IIIA Non-Small Cell Lung Cancer
Interventions: Drug: Neoadjuvant Cisplatin, nab-paclitaxel;   Drug: Adjuvant Cisplatin,nab-paclitaxel;   Drug: Adjuvant cisplatin+pemetrexed or cisplatin+gemcitabine
19 Recruiting Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
Condition: Non-small Cell Lung Cancer
Intervention: Other: Gefitinib
20 Unknown  Study of Efficacy of Induction Chemotherapy With Gemcitabine and Carboplatin for Operable Non-small-cell Lung Cancer Before Surgery
Condition: Lung Neoplasms
Interventions: Drug: gemcitabine, carboplatin;   Procedure: surgery

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years